Faculty Information - OMOTO Kazuya

（Last updated : 2024-04-17 15:32:04）

OMOTO Kazuya
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Assistant Professor

■ Published papers

1.	Original article	The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks 2024/01/09
2.	Original article	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. 2023/11
3.	Original article	A case of kidney transplantation for complete C4 deficiency with recurrent IgM-monoclonal gammopathy of renal significance (MGRS) associated nephropathy. 2023/09
4.	Case report	Kidney transplantation after multiple urinary tract conversion with an ileal conduit: A case report. 2023/05/14
5.	Original article	Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. 2023/05/04
6.	Original article	Case report: suspected hyperacute rejection during living kidney transplantation. 2023/05/01
7.	Original article	Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan academic consortium of kidney transplantation study-II. 2023/05
8.	Case report	Allogeneic kidney transplantation after COVID-19: A case report. 2022/07
9.	Case report	Case report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. 2022/07
10.	Case report	Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report. 2022/07
11.	Original article	Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: A retrospective cohort study at a single transplant institute in Japan. 2022/05
12.	Original article	Japanese single-center experience of kidney transplant: Experience in a Japanese private hospital. 2022/03
13.	Original article	Safe Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg. 2022/03
14.	Case report	Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report. 2022/01
15.	Case report	Fluorescence in situ hybridization for the origin of de novo renal cell carcinoma in a kidney allograft: A case report. 2021/10
16.	Original article	Desensitization Regimen Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab (an Anti-CD20 Antibody), Without Eculizumab and/or Bortezomib, in 41 Highly Sensitized Kidney Transplant Recipients 2021/09/08
17.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation. 2021/06
18.	Review article	The significance of HLA antibody screening test. 2020/12/10
19.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7-years of follow-up after renal transplantation. 2020/12
20.	Original article	Clinicopathologic analyses of chronic vascular rejection after kidney transplantation. 2020/07
21.	Original article	Post-donation satisfaction in kidney transplantation: a survey of living donors in Japan 2019/10/26
22.	Original article	Predictors of return to work after kidney transplantation: a 12-month cohort of the Japan Academic Consortium of Kidney Transplantation study 2019/10/03
23.	Original article	Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance - an experimental study. 2019/04
24.	Original article	Monoclonal immunoglobulin G deposits on tubular basement membrane in renal allograft: is this significant for chronic allograft injury? 2019/04
25.	Original article	Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible:A randomized trial. 2018/12
26.	Original article	Clinical and Pathological Features of Plasma Cell-Rich Acute Rejection After Kidney Transplantation. 2018/05
27.	Original article	iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model. 2018/02
28.	Original article	Evaluation of microvascular inflammation in ABO-incompatible kidney transplantation. 2017/06
29.	Original article	Assessment of 4 cases of kidney transplantation from hepatitis C virus antibody-positive and RNA-negative donors to antibody-negative recipients. 2016/09
30.	Original article	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2016/07
31.	Case report	Successful kidney transplantation after stepwise desensitization using rituximab and bortezomib in a highly HLA-sensitized and ABO incompatible high titer patient. 2016/07
32.	Case report	Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab. 2016/07
33.	Original article	Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up. 2016/05
34.	Original article	Post-transplant lymphoproliferative disorder in kidney transplant recipients: A single-center experience in Japan. 2016/04
35.	Original article	Preemptive living donor kidney transplantation and kidney function at the initial hospital visit: A single-center casee-control study. 2016/04
36.	Original article	Robot-assisted radical prostatectomy for localized prostate cancer in asian renal transplant recipients. 2016/04
37.	Original article	ABO-Incompatible living kidney transplants: Evolution of outcomes and immunosuppressive management. 2016/03
38.	Original article	Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer. 2016/03
39.	Original article	Reliability of tacrolimus determination using Electro-Chemiluminesence Immunoas-say(ECLIA). 2016/03
40.	Original article	Clonal deletion established via invariant NKT cell activation and costimulatory blockade requires in vivo expansion of regulatory T cells. 2016/02
41.	Original article	Effects of low-dose rituximab therapy in patients with primary cytomegalovirus infection. 2015/12
42.	Original article	Evaluation of the variability among two reference Flow Cytometry Crossmatch. 2015/10
43.	Original article	Plasma cell-rich rejection after kidney transplantation and the role of donor-specific antibodies: A case report and review of the literature. 2015/10
44.	Case report	A Case of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation Associated With Variant Conversion in the Columbia Classification 2015/07
45.	Original article	Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015/07
46.	Original article	The impact of C4d-negative acute antibody-mediated rejection on short-term prognosis among kidney transplant recipients. 2015/07
47.	Original article	Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer. 2015/06
48.	Original article	Evaluation of assay methods for tacrolimus concentration on renal transplantation-CLIA, EMIT, and ECLIA- 2015/03
49.	Original article	Retroperitoneoscopic donor nephrectomy with multiple renal arteries does not affect graft survival and ureteral complications. 2014/12
50.	Other	The phenotype of repopulating B cell after rituximab therapy in kidney transplant patients. 2014/11
51.	Original article	Influence of dialysis duration on the outcome of living kidney transplantation. 2014/10
52.	Original article	Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients. 2014/08
53.	Other	The authors' reply 2014/08
54.	Original article	Clinical and pathological analyses of transplant glomerulopathy cases. 2014/06
55.	Original article	A Novel Approach Inducing Transplant Tolerance by Activated Invariant Natural Killer T Cells With Costimulatory Blockade 2014/03
56.	Original article	Influence of Dialysis Duration on the Outcome of Living Kidney Transplantation 2014/02
57.	Original article	Impact of right-sided nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy at single center 2013/10
58.	Original article	Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model 2013/10
59.	Original article	Detectability of Renal Arteries in Living Renal Donors Using Multi-Detector CT: Comparison among Axial and Three-Dimensional Reconstruction Images 2013/09
60.	Original article	Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome 2013/09
61.	Original article	Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation: Prospective Trial in Once-Daily Versus Twice-Daily Tacrolimus 2013/07
62.	Original article	A case of focal segmental glomerulosclerosis diagnosed as the original underlying disease after cadaveric renal transplantation 2012/09
63.	Original article	Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection 2012/09
64.	Original article	Interleukin-6 Receptor Signaling Disruption Prevents Cardiac Allograft Deterioration in Mice 2012/08
65.	Original article	Acute vascular rejection after renal transplantation and isolated v-lesion 2012/07
66.	Original article	Clinical and pathological analysis of transplant glomerulopathy cases 2012/07
67.	Original article	Improvement of Urinary Dysfunction After Kidney Transplantation by Administration of the Antimuscarinic Agent-Prospective Randomized Controlled Study 2012/03
68.	Original article	Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period 2012/02
69.	Original article	Clinicopathologic Analysis of Acute Vascular Rejection Cases After Renal Transplantation 2012/02
70.	Original article	Kidney Transplantation at Tokyo Women's Medical University 2012
71.	Original article	The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience 2011/11
72.	Original article	Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy 2011/02
73.	Original article	Kidney Transplantation at Tokyo Women's Medical University 2011
74.	Original article	Bladder function of end-stage renal disease patients 2010/09
75.	Original article	Clinicopathological analysis of acute vascular rejection cases after renal transplantation. 2010/07
76.	Original article	New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. 2010
77.	Original article	Retroperitoneoscopic living donor nephrectomy: experience of 425 cases at a single center. 2010
78.	Original article	Risk factors for deterioration of renal function after donor nephrectomy 2010
79.	Original article	Clinicopathological analysis of transplant glomerulopathy cases 2009/08
80.	Original article	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation:Long-term impact and risk factors 2009
81.	Original article	Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation 2009
82.	Original article	A case of plasma cell-rich acute rejection 18 months after kidney transplantation successfully treated with steroid pulse therapy 2008/07
83.	Original article	Continent Orthotopic Ileal Neobladder After Kidney Transplantation in a Patient With Urothelial Cell Carcinoma Associated With Chinese Herb Nephropathy 2008/06
84.	Original article	Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation 2008/06
85.	Original article	Analysis of Renal Transplant Protocol Biopsies in ABO-Incompatible Kidney Transplantation 2008/01
86.	Original article	Clinical and Histological Analysis of Chronic Tacrolimus Nephrotoxicity in Renal Allografts 2008
Display 5 items
Display all(86)

■ Academic conference presentation

1.	Elderly living kidney transplant donors and their renal prognosis. 2023/06/06
2.	Safety and efficacy of hypoxia-inducible factor prolyl hydroxylase inhibitor in kidney transplant patients with post-transplant anemia. 2023/06/05
3.	Effects and side effects of desensitization therapy in flow cytometry crossmatch-negative, Low-dose donor-specific antibody-positive renal transplant recipients. 2023/06/04
4.	Impact of current desensitization protocols and surgical outcomes in ABO-incompatible kidney transplant recipients: A Japanese single-center experience. 2023/06/04
5.	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. 2023/06/03
6.	Outcomes of kidney transplantation recipients with Covid-19 infection : 282 Cases of a Single-Center experience. 2023/06/03
7.	Sars-Cov-2 antibody kinetics after vaccination in solid organ transplant recipients: multicenter study. 2023/06/03
8.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. 2023/06/03
9.	A case of renal transplantation with CAAMR revealed by a novel HLA antibody approach. 2023/04/29
10.	Postoperative management of renal transplantation: what you need to know. 2023/04/21
11.	10-years long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation. 2023/04/20
12.	A case of living kidney transplantation suspected of hyper-acute rejection during kidney transplant surgery. 2022/11/26
13.	Antibody response after SARS-CoV-2 mRNA vaccines in previously infected kidney transplant recipients. 2022/11/26
14.	Clinicopathological analyses of chronic vascular rejection after kidney transplantation. 2022/11/26
15.	Cost effectiveness of kidney transplantation in high-immunological risk patients in a Japan cohort. 2022/11/26
16.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. 2022/11/26
17.	Outcomes of ABO-compatible living kidney transplantation recipients with low immunological risk. 2022/11/26
18.	Outcomes of kidney transplantation recipients with SARS-CoV-2 infection: A single-center experience. 2022/11/26
19.	SARS-CoV-2 antibody kinetics after second dose of vaccination in solid organ transplant recipients. 2022/11/26
20.	A case of kidney transplantation after multiple urinary tract conversion with an ileal conduit. 2022/11/25
21.	Evaluation of cases of cytomegalovirus infection after renal transplantation at our department. 2022/11/25
22.	Preconception care and pregnancy complications after kidney transplantation: A single-center study. 2022/11/25
23.	Recurrence of cancer in 188 kidney transplant recipients. 2022/11/25
24.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. 2022/10/24
25.	Desensitization protocol to prevent severe oliguric antibody-mediated rejection. 2022/06/05
26.	SARS-CoV-2 antibodies transitions after vaccination in solid organ transplant recipients: Multicenter study in Japan. 2022/06/05
27.	Two times or more double-filtration plasmapheresis increases the risk of bleeding during kidney transplantation. 2022/06/05
28.	Relationship between tacrolimus blood levels and covid-19 pandemic in kidney transplant recipients. 2021/06/04
29.	The evaluation of living-related kidney transplantation donors in autosomal-dominant polycystic kidney disease. 2021/06/04
30.	Pathological investigation about renal transplant lost allografts. 2020/12/23
31.	Quantitative analysis of humoral immunity by flow-cytometric crossmatch using molecules of equivalent soluble fluorochromosome (FCXM-MESF). 2020/05/30
32.	Correlation between the HLA antibody screening test and the specificity identification test. 2019/09/15
33.	Pregnancy outcomes in kidney transplant recipients. 2019/06/03
34.	Return to work after sick leave in kidney transplant recipients: A 365day cohort of the Japan academic consortium of kidney transplantation (JACK) study. 2019/06/03
35.	Clinical and pathological analysis of chronic vascular rejection after renal transplantation. 2018/07/21
36.	Outcomes of retroperitoneoscopic live donor nephrectomy (RPLDN): Experience of 1100 cases at a single center. 2018/06/04
37.	Recurrence of immunoglobulin a nephropathy in related donor kidney transplant recipients. 2018/06/03
38.	Relation between seroprevalence of cytomegalovirus and graft survival in Japanese kidney transplant recipients: The Japan academic consortium of kidney transplantation study. 2018/06/02
39.	Monoclonal IgG Deposits on Tubular Basement Membrane in Renal Allograft: Is This Significant for Chronic Allograft Injury? 2017/11/04
40.	Once-daily versus twice-daily tacrolimus in living kidney transplantation: A Multicenter, parallel group, open-label, 5-year, randomized non-inferiority trial. 2017/05/02
41.	Renal transplantation to the extraperitoneal cavity in children weighing less than 15 kg can be performed safely. 2017/05/02
42.	A comparative study of patient and graft qualities between abo- compatible and- incompatible recipients more than ten years after kidney transplantation. 2017/05/01
43.	Manipulate innate immune cells; breakthrough for acquiring transplant tolerance. 2017/03/25
44.	Combination of veto cell transfer and NKT cell therapy helps establish complete hematopoietic chimerism in non-myeloablative BMT recipients. 2016/12/06
45.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: Evolution of outcomes and immunosuppressive management. 2016/10/29
46.	Post-transplant diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. 2016/08/23
47.	Clinical and pathological analyses of interstitial fibrosis and tubular atrophy (IF/TA) cases after kidney transplantation. 2016/08/20
48.	Comparison of the pharmacokinetics and pathology for low-dose once-daily and twice-daily tacrolimus following living kidney transplantation: Five-year results from a prospective trial. 2016/08/20
49.	Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation: Is prophylactic treatment necessary? 2016/08/20
50.	Relationship between dialysis duration and prevalence of cardiovascular diseases in kidney transplantation recipients. 2016/08/20
51.	Pharmakokinetics of prolonged-release formulation of tacrolimus:Comparison of AUC0-24 and concentration at 10 time points. 2016/06/13
52.	Relationship between dialisys duration and prevalence of cardiovascular diseases in kidney transplantation recipients. 2016/06/13
53.	The significance of microvascular inflammation in antibody-mediated rejection in ABO-incompatible kidney transplantation. 2016/06/13
54.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: evolution of outcomes and immunosuppressive management. 2016/06/11
55.	Association between pretransplant body mass index and outcomes in patients undergoing living kidney transplantation: A consideration of gender differences. 2016/06/11
56.	Clinical outcome of elderly living kidney donors: A single-center study in Japan. 2016/06/11
57.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation - Prospective trial of once-daily vs.twice-daily Tac - 5 years second report. 2016/06/11
58.	Sequential analysis of donor-specific antibodies and pathological findings using intravenous immunoglobulin in a highly sensitized rat kidney transplant model. 2016/06/11
59.	An Investigation of 13 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation 2015/11/07
60.	Successful ABO-blood group incompatible kidney transplantation under eculizumab induction. 2015/09/13
61.	Short-term outcomes of angioplasty in situ for renal artery aneurysm. 2015/05/18
62.	Incidence of hepatitis B virus reactivation in kidney transplant patients who received rituximab administration. 2015/05/05
63.	The clinical outcome of plasma cell-rich rejection of kidney allograft. 2015/05/05
64.	Regulatory T cells expanded by activated iNKT cells facilitate migration of donor dendritic cells into the recipient thymus and subsequent establishment of clonal deletion. 2015/05/04
65.	The effect of rituximab therapy on regulatory B cell and prevention of chronic antibody mediated rejection in kidney transplantation recipients. 2015/05/04
66.	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2015/05/03
67.	Outcome of kidney transplantation from obese living donors: Histological evaluation using zero-time biopsy specimens. 2015/05/03
68.	Outcome of kidney transplantation from older living donors: Histological evaluation using zero-time biopsy specimens. 2015/05/03
69.	Outcome of kidney transplantation using right versus three left renal arteries after retroperitoneoscopic donor nephrectomy:A single-center experience of 764 cases. 2015/05/03
70.	T cell transfer with iNKT cell activation facilitate engraftment of bone marrow cells without GvHD. 2015/05/03
71.	An Investigation of 12 cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation 2015/05/02
72.	Donor specific tolerance can be induced by donor bone marrow transfer with activation of invariant naturel killer T cells. 2015/05/02
73.	Excellent outcomes of prophylactic rituximab administration with plasmapheresis in kidney transplant recipients with focal segmental glomerulosclerosis. 2015/05/02
74.	Intimal arteritis associated with subsequent graft dysfunction in ABO-incompatible kidney transplantation. 2015/05/02
75.	Impact of right nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy. 2014/09/04
76.	Efficacy of rituximab, an anti-CD20 antibody for preventing hemolysis due to passenger leucocyte syndrome (PLS). 2014/07/30
77.	A novel approach inducing transplant tolerance by activated invariant natural killer T cells with co-stimulatory blockade. 2014/07/29
78.	Analysis of predictive and preventive factors for de novo DSA in Non-HLA sensitized kidney transplant recipients. 2014/07/29
79.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation -prospective trial of once-daily vs. twice-daily tac -3 years second report. 2014/07/29
80.	Long-term (more than 20 years) outcome of ABO-incompatible living donor kidney transplantation: A single center experience. 2014/07/29
81.	Outcomes of pure retroperitoneoscopic live donor nephrectomy (RPLDN): single center experience of 764 cases. 2014/07/29
82.	Outcomes of retroperitoneoscopic live donor nephrectomy in patients with renal artery aneurysm. 2014/07/29
83.	Retroperitoneoscopic procurement of kidneys with multiple renal arteries does not affect graft survival and ureteral complications. 2014/07/29
84.	Risk factors of preterm delivery at less than 35 weeks in patients with kidney transplantation. 2014/07/29
85.	The correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression including rituximab. 2014/07/29
86.	Assessment of long-term outcomes after kidney retransplantation. 2014/07/28
87.	Low incidence of new onset diabetes mellitus after renal transplantation under low-dose tacrolimus-based immunosuppression: A single center experience. 2014/07/28
88.	Lower incidence rate of BK virus nephropathy, as detected by PCR screening, associated with lower doses of Tac/MMF at Tokyo Women's Medical University. 2014/07/28
89.	No necessity for prophylactic B-Cell-targeting treatment for postoperative high titers of anti-blood type antibodies after ABO-incompatible living related kidney transplantation. 2014/07/28
90.	Association between age and kidney transplantation outcome: Does age matter? 2014/07/27
91.	Changes in ABO-blood type antibody titers after single-dose rituximab administration. 2014/07/27
92.	Influences of the CD20 Ab rituximab on the renal transplant recipients and renal grafts 5 to 8 years after immunologically high-risk renal transplantation. 2014/07/27
93.	Long-term outcomes of living donor kidney transplantation in flow cytometry crossmatch-positive patients: A single-center experience. 2014/07/27
94.	Preliminary outcome of desensitization with super high dose IVIG, plasmapheresis, and rituximab for crossmatch-positive (highly sensitized) kidney transplant recipients. 2014/07/27
95.	A case of recurrent FSGS diagnosed as underlying disease following deceased donor kidney transplantation and a review of recurrent FSGS cases after transplantation at our institution 2013/09/04
96.	Evaluation of the association between histological findings of arteriosclerosis in zero-time biopsy and tacrolimus-induced nephrotoxicity 2013/09/04
97.	Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment 2013/05/21
98.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for over 20 Years 2013/05/21
99.	Incidence of Malignancy after Kidney Transplantation in the New Era of Immunosuppression 2013/05/21
100.	Evaluation of Low-Dose Rituximab Treatment;the Incidence of Graft Rejection and Adverse Events in 313 Living Kidney Transplant Recipients 2013/05/20
101.	Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity 2013/05/19
102.	Development of De Novo Anti-HLA Antibodies after Treatment with/without Rituximab, a BCell-Depleting Treatment 2013/05/19
103.	Influence of Preoperative Anti-HLA Antibodies on Short-Term and Long-Term Graft Survival in Recipients With or Without Rituximab Treatment 2013/05/19
104.	Microvascular Inflammation as a Core Element of Diagnostic Criteria of Antibody-Mediated Rejection(ABMR): C4d Positivity Is Not Reliable Element in Diagnosis of ABMR 2013/05/19
105.	Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model 2013/05/19
106.	The Significance of Low Level DSA Detected by Solid Phase Assay in Association with Acute and Chronic Antibody Mediated Rejection 2013/02/09
107.	MFI Detected by Luminex in Patients with Chronic Active Antibody Mediated Rejection 2012/10/20
108.	Outcomes of Retroperitoneoscopic Procurement of Kidneys with Multiple Renal Arteries 2012/10/20
109.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases 2012/07/19
110.	Clinicopathological Analysis of Acute Vascular Rejection Cases after Renal Transplantation 2012/07/19
111.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for Over 20 Years 2012/07/19
112.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome(FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation 2012/07/19
113.	The Signifi cance of Low Level DSA Detected by Solid Phase Assay in Association with Acute and Chronic Antibody Mediated Rejection 2012/06/05
114.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases 2012/06/04
115.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome (FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation 2012/06/04
116.	The Impact of B-Cell Depleting Treatment on Marked Reduction of Chronic Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation 2012/06/04
117.	An Open Label, Prospecive Randomized Controlled Study Comparing Tacrolimus Once-Daily and Twice-Daily in De Novo Kidney Transplatation: Pharmacokinetics and Pathological Analysis by Protocol Biopsy 2012/06/03
118.	Long-Term Follow-Up of Kidney Transplant Recipient with Calcineurin Inhibitor-Associated Nephrotoxicity 2012/06/03
119.	Neutrophil Gelatinase-Associated Lipocalin Is Most Sensitive to the Acute Rejection after Living Donated Kidney Transplantation 2012/06/03
120.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years 2012/06/02
121.	Impact of Right-sided Nephrectomy on Long-term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy 2012/04/23
122.	Detectability of renal arteries in living renal donors using MDCT: comparison among axial images and three-dimensional reconstruction images 2012/03
123.	Prophylactic therapy for antibody-mediated rejection during introductory period in kidney transplantation(Symposium7 Antibody-mediated rejection in kidney transplantation) 2012/02/03
124.	Impact of Right Nephrectomy on Long-Term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy 2011/11/30
125.	Chimerism of blood type antigens on the vessel endothelium in patients with antibody-mediated rejection 2011/09/04
126.	Clinicopathological analysis of acute vascular rejection cases after renal transplantation 2011/06
127.	Impact and Implication of Renal Artery Number on Outcomes of Renal Donors and Recipients in Retroperitoneoscopic Live Donor Nephrectomy-Experience of 500 Cases at a Single Center 2011/05/03
128.	Impact of Right Nephrectomy on Long-Term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy:Experience of 479 Cases at a Single Center 2011/05/03
129.	Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 500 Cases at a Single Center 2011/05/03
130.	Excellent Outcomes of Rituximab Administration Plus Plasmapheresis as Prophylactic Treatment Prior to Kidney Transplantation in Patients with Focal Segmental Glomerulosclerosis 2011/05/02
131.	Decrease of Blood-Type Antigenicity over the Long-Term after ABO-Incompatible Kidney Transplantation 2011/05/01
132.	Significance of Qualitative and Quantitative Evaluations of Anti-HLA Antibodies in Kidney Transplantation 2011/05/01
133.	Significant Reduction in Chronic Antibody-Mediated Rejection after B-Cell Depleting Treatment in ABO-Incompatible Living Kidney Transplantation 2011/05/01
134.	Rituximab Therapy Reduces Peripheral B Cells for a Long Time in ABO Incompatible Kidney Transplantation; a Single Center Experience 2011/04/30
135.	The Efficacy of Interleukin-6 Receptor Signaling Blockade during Acute and Chronic Rejection in a Cardiac Allograft Transplantation Murine Model 2011/04/30
136.	MRI findings of the post-transplant lymphoproliferative disorder (PTLD) of the central nervous system (CNS) 2010/05/10
137.	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors 2010/05
138.	Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation 2010/05
139.	Complications and excellent graft functions of retroperitoenoscopic living donor nephrectomy at single center experiment 2010/05
140.	Excellent long-term outcomes of donor-specific anti-HLA antibody(DSA) positive renal transplant recipients and significant elimination of posttransplant DSA by combination treatment of basiliximab and rituxaimab inductoin 2010/05
141.	Impact of right nephrectomy on outcomes of renal function and complications in retroperitoneoscopic live donor nephrectomy:experience of 425 cases at a single center 2010/05
142.	Lymphopenia-induced proliferation of lymphocytes results in chronic rejection of mice cardiac allografts 2010/05
143.	Lymphopenia-indued proliferation of lymphocytes results in chronic rejection of mice cardiac allografts 2010/05
144.	Outcome of kidney transplantation from living older donors: histologiucal evaluation using zero-time biopsy 2010/05
145.	Outcome of retroperitoneoscopic living donor nephrectomy in obese donors 2010/05
146.	The effect of anti IL-6 receptor monoclonal antibody during acute and chronic rejection in a cardiac allograft transplantation murine model 2010/05
Display 5 items
Display all(146)

■ Research areas

Urology, Immunology (Key Word：kidney transplantation, immunological tolerance, bone marrow transplantation)

■ Education

1992/04～1996/03

〔Doctoral course〕 Speciality, Division of Surgery, Graduate School, Division of Medical Sciences, Kyushu University, Completed, Doctor of Medicine, Doctor of Philosophy